Page last updated: 2024-08-26

nimbolide and deoxycytidine

nimbolide has been researched along with deoxycytidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Attwood, K; Balachandar, S; Chandra, D; Chaudhary, AK; Hochwald, S; Inigo, JR; Kumar, R; Kumar, S; O'Malley, J; Wang, J; Wang, X; Yadav, N	1

Other Studies

1 other study(ies) available for nimbolide and deoxycytidine

Article	Year
Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer letters, 2018, 01-28, Volume: 413 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Pancreatic Ductal; Caspase Inhibitors; Cell Line, Tumor; Cell Movement; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Hyaluronan Receptors; Limonins; Mitochondria; Mutation; Neoplastic Stem Cells; Pancreatic Neoplasms; Reactive Oxygen Species; Time Factors; Tumor Suppressor Protein p53	2018

Article

Year

Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells.

Cancer letters, 2018, 01-28, Volume: 413

Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Pancreatic Ductal; Caspase Inhibitors; Cell Line, Tumor; Cell Movement; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Hyaluronan Receptors; Limonins; Mitochondria; Mutation; Neoplastic Stem Cells; Pancreatic Neoplasms; Reactive Oxygen Species; Time Factors; Tumor Suppressor Protein p53

2018